Inovio Pharmaceuticals, Inc. (INO)
1.36
+0.03
(+2.26%)
USD |
NASDAQ |
Sep 02, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Cash from Investing (Quarterly) : 6.147M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.147M |
| March 31, 2026 | 2.636M |
| December 31, 2025 | -0.0582M |
| September 30, 2025 | 8.867M |
| June 30, 2025 | 5.282M |
| March 31, 2025 | -0.0518M |
| December 31, 2024 | 34.64M |
| September 30, 2024 | 14.08M |
| June 30, 2024 | 9.966M |
| March 31, 2024 | 45.38M |
| December 31, 2023 | 19.94M |
| September 30, 2023 | -5.494M |
| June 30, 2023 | 53.91M |
| March 31, 2023 | 19.00M |
| December 31, 2022 | 54.00M |
| September 30, 2022 | 44.56M |
| June 30, 2022 | -10.30M |
| March 31, 2022 | 21.33M |
| December 31, 2021 | -6.494M |
| September 30, 2021 | 55.96M |
| June 30, 2021 | 50.31M |
| March 31, 2021 | -275.12M |
| December 31, 2020 | -3.716M |
| September 30, 2020 | 39.11M |
| June 30, 2020 | -42.18M |
| Date | Value |
|---|---|
| March 31, 2020 | -49.64M |
| December 31, 2019 | 10.38M |
| September 30, 2019 | 8.270M |
| June 30, 2019 | 21.57M |
| March 31, 2019 | -46.31M |
| December 31, 2018 | 7.183M |
| September 30, 2018 | 14.42M |
| June 30, 2018 | -5.985M |
| March 31, 2018 | 26.80M |
| December 31, 2017 | 14.58M |
| September 30, 2017 | -54.16M |
| June 30, 2017 | -6.423M |
| March 31, 2017 | 18.17M |
| December 31, 2016 | 9.918M |
| September 30, 2016 | 9.073M |
| June 30, 2016 | -2.382M |
| March 31, 2016 | -0.3382M |
| December 31, 2015 | -21.22M |
| September 30, 2015 | -1.981M |
| June 30, 2015 | -29.29M |
| March 31, 2015 | -2.330M |
| December 31, 2014 | -23.22M |
| September 30, 2014 | -10.32M |
| June 30, 2014 | -2.992M |
| March 31, 2014 | 0.7186M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Fortress Biotech, Inc. | -0.079M |
| Tonix Pharmaceuticals Holding Corp. | -0.5769M |
| Kura Oncology, Inc. | 92.21M |
| Spero Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -18.05M |
| Cash from Financing (Quarterly) | 17.16M |
| Free Cash Flow | -80.78M |
| Free Cash Flow Per Share (Quarterly) | -0.2211 |
| Free Cash Flow to Equity (Quarterly) | -17.35M |
| Free Cash Flow to Firm (Quarterly) | -18.05M |
| Free Cash Flow Yield | -87.38% |